Business Description
Baudax Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US07160F4046
Share Class Description:
BXRXQ: Ordinary SharesDescription
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs and a dedicated reversal agent.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 900 | |||||
12-1 Month Momentum % | 900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1127.34 | |||||
OCF Margin % | -1127.34 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.24 | |||||
FCF Yield % | -1685700 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BXRXQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baudax Bio Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.269 | ||
| EPS (TTM) ($) | -9.23 | ||
| Beta | -57.468 | ||
| 3-Year Sharpe Ratio | 0.21 | ||
| 3-Year Sortino Ratio | 1.05 | ||
| Volatility % | 900 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.000006 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | 900 | ||
| 52-Week Range ($) | 0.000001 - 0.0001 | ||
| Shares Outstanding (Mil) | 43.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baudax Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baudax Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 105 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 20 days | ||
| First quarter earnings results for 2026 | 2026-08-03 | In 3 days | ||
| 0.025:1 Stock Split | 2022-12-01 | 5.82 (-1.69%) | ||
| 0.028571:1 Stock Split | 2022-02-16 | 251.30 (+0.28%) |
Show
Entries
Baudax Bio Inc Frequently Asked Questions
What is Baudax Bio Inc(BXRXQ)'s stock price today?
The current price of BXRXQ is $0.00. The 52 week high of BXRXQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Baudax Bio Inc(BXRXQ)?
The next earnings date of Baudax Bio Inc(BXRXQ) is 2026-08-03 Est..
Does Baudax Bio Inc(BXRXQ) pay dividends? If so, how much?
Baudax Bio Inc(BXRXQ) does not pay dividend.
Guru Commentaries on OTCPK:BXRXQ
No articles.
Press Release
Articles on Baudax Bio Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers